Fluticasone/salmeterol (Advair) is a combination of two medications to reduce the number and severity of asthma attacks. In this video, learn how to take fluticasone/salmeterol to improve treatment outcomes, according to Joshua Murdock, PharmD, Sr. Pharmacy Editor at GoodRx.
Joshua Murdock, PharmD is a pharmacy editor for GoodRx. He earned his Doctor of Pharmacy degree from Butler University in Indianapolis, Indiana and is licensed in Colorado and Rhode Island.
References
American Academy of Allergy, Asthma, and Immunology. (n.d.). Bronchospasm defined.
American Lung Association. (2022). How to use a metered-dose inhaler without a valved holding chamber.
American Lung Association. (2023). How to use a Diskus asthma inhaler.
American Lung Association. (2023). Measuring your peak flow rate.
DelGaudio, J. M., et al. (2002). Steroid inhaler laryngitis. Journal of the American Medical Association Otolaryngology- Head and Neck Surgery.
Donohue, J. F., et al. (2021). Wixela Inhub: A generic equivalent treatment option for patients with asthma or COPD. Pulmonary Therapy.
GlaxoSmithKline LLC. (2023). Advair Diskus- fluticasone propionate and salmeterol powder [package insert]. DailyMed.
GlaxoSmithKline LLC. (2023). Advair HFA- fluticasone propionate and salmeterol xinafoate aerosol, metered [package insert]. DailyMed.
MedlinePlus. (2016). Cushing’s syndrome.
Mylan Pharmaceuticals Inc. (2022). Wixela Inhub- fluticasone propionate and salmeterol powder [package insert]. DailyMed.
Namazy, J. A., et al. (2014). The safety of asthma medications during pregnancy: An update for clinicians. Therapeutics Advances in Respiratory Disease.
National Institute of Diabetes and Digestive and Kidney Diseases. (2018). Definition & facts of adrenal insufficiency & Addison's disease.
Tashkin, D. P., et al. (2018). Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: A matched-subgroup post hoc analysis of the UPLIFT® trial. Respiratory Research.
van Boven, J. F. M., et al. (2013). Inhaled corticosteroids and the occurrence of oral candidiasis: A prescription sequence symmetry analysis. Drug Safety.
Wang, Z., et al. (2022). Medication cost-savings and utilization of generic inhaled corticosteroid (ICS) and long-acting beta-agonist (LABA) drug products in the USA. Therapeutic Innovation & Regulatory Science.
Why trust our experts?













